Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors.



Our latest research published in ACS Chemical Biology


https://pubs.acs.org/doi/10.1021/acschembio.8b00665


Targeting the protein–protein interaction between p53 and MDM2/MDMX (MDM4) represents an attractive anticancer strategy for the treatment of p53-competent tumors. Several selective and potent MDM2 inhibitors have been developed and entered the clinic; however, the repertoire of MDMX antagonists is still limited. The arylmethylidenepyrazolinone SJ-172550 has been reported as a selective MDMX antagonist; yet, uncertainties about its mechanism of action have raised doubts about its use as a chemical probe. Here, we show that, in addition to its unclear mode of action, SJ-172550 is unstable in aqueous buffers, giving rise to side products of unknown biological activity. Using an SJ-172550-derived affinity probe, we observed promiscuous binding to cellular proteins whereas cellular thermal shift assays did not reveal a stabilizing effect on MDMX. Overall, our results raise further questions about the interpretation of data using SJ-172550 and related compounds to investigate cellular phenotypes.

ox_small_special_pos.png
multi-coloured-men-square-large.jpeg
10750466_350098438505680_393264791048932
18-oxford-tgi-283x94px.jpg

©2019 by Huber Lab.